Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
510 A PD-L1 reporter cell line based on the immune checkpoint protein profiling of ATCC cell lines facilitates cancer immunotherapy drug screening
Compose a Response to This Article
Other responses
No responses have been published for this article.